Research ties diabetic foot ulcers to higher ESRD costs

04/24/2014 | Renal and Urology News

Data on patients with end-stage renal disease showed those who had diabetic foot ulcers required more erythropoiesis-stimulating agents and had higher monthly inpatient and outpatient costs than those without DFU. The findings were presented at a National Kidney Foundation meeting.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA